Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ROPINIROLE HYDROCHLORIDE USP, with a corresponding US DMF Number 20593.
Remarkably, this DMF maintains an Active status since its submission on June 12, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 16, 2022, and payment made on November 14, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II